Increased production of intestinal immunoglobulins in Syntenin-1-deficient mice  by Tamura, Kentaro et al.
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Syntenin-1  is  an  intracellular  PDZ  protein  that  binds  multiple  proteins  and  regulates  protein  trafﬁcking,
cancer  metastasis,  exosome  production,  synaptic  formation,  and  IL-5  signaling.  However,  the  functions
of Syntenin-1  have  not  yet  been  clearly  characterized  in  detail,  especially  in  vivo.  In  this  study,  we gen-
erated a Syntenin-1  knock  out (KO)  mouse  strain  and  analyzed  the  role(s)  of  Syntenin-1  in  IL-5  signaling,
because  the direct  interaction  of Syntenin-1  with  the  cytoplasmic  domain  of  the  IL-5 receptor    sub-
unit  and  the  regulation  of  IL-5  signaling  by Syntenin-1  have  been  reported.  Unexpectedly,  the  number
of  IL-5-responding  cells  was  normal  and  the  levels  of  fecal  immunoglobulins  were  rather  higher  in the
Syntenin-1  KO  mice.  We  also  found  that  IgA  and IgM  production  of  splenic  B cells  stimulated  in vitroucosal immunity
yntenin-1
was  increased  in  Syntenin-1  KO  mice.  In addition,  we  showed  that  a distribution  of intestinal  microbial
ﬂora  was  inﬂuenced  in Syntenin-1  KO  mice.  Our  data  indicate  that  Syntenin-1  negatively  regulates  the
intestinal  immunoglobulin  production  and has  a function  to maintain  the intestinal  homeostasis  in vivo.
The analysis  of  Syntenin-1  KO mice  may  provide  novel  information  on  not  only  mucosal  immunity  but
also  other  functions  of Syntenin-1  such  as cancer  metastasis  and  neural  development.
©  2014  The  Authors.  Published  by  Elsevier  GmbH.  This  is an  open  access  article  under  the CCntroductionSyntenin-1 (Syndecan-binding protein, Sdcbp) was  ﬁrst iden-
iﬁed as an intracellular scaffold protein interacting with the
ransmembrane heparan sulfate syndecans (Grootjans et al., 1997).
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ervous system; ES, embryonic stem; IL-5R, interleukin-5 receptor  subunit; KO,
nock out; L-LP, large intestinal lamina propria; LP, lamina propria; PC, peritoneal
avity; PDZ, PSD-95/Discs large/zO-1; PEC, peritoneal exudate cells; PP, Peyer’s
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T,  wild type.
∗ Corresponding author at: Department of Molecular Neuroscience, Graduate
chool of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugi-
ani, Toyama 930-0152, Japan. Tel.: +81 76 434 7230; fax: +81 76 434 5015.
∗∗ Corresponding author at: Department of Immunobiology and Pharmacological
enetics, Graduate School of Medicine and Pharmaceutical Sciences, University of
oyama, 2630 Sugitani, Toyama 930-0152, Japan. Tel.: +81 76 434 7673;
ax:  +81 76 434 5009.
E-mail addresses: mikutani@med.u-toyama.ac.jp (M. Ikutani),
mori@med.u-toyama.ac.jp (H. Mori).
ttp://dx.doi.org/10.1016/j.imbio.2014.12.003
171-2985/© 2014 The Authors. Published by Elsevier GmbH. This is an open acces
y-nc-sa/3.0/).BY-NC-SA  license  (http://creativecommons.org/licenses/by-nc-sa/3.0/).
It was  also termed melanoma differentiation-associated gene-9
(MDA-9), which promoted cancer metastasis by regulating cell
adhesion (Boukerche et al., 2005, 2007, 2008; Lin et al., 1998). Sub-
sequently, Syntenin-1 has been reported to act as a multifunctional
intracellular adapter protein and to regulate protein trafﬁcking and
recycling (Zimmermann et al., 2005), Notch signaling (Estrach et al.,
2007), IL-5 signaling (Beekman et al., 2009; Geijsen et al., 2001), T
cell chemotaxis (Sala-Valdes et al., 2012), HIV infection (Gordon-
Alonso et al., 2012), exosome production (Baietti et al., 2012), and
synaptic formation in CNS (Hirbec et al., 2005; Jannatipour et al.,
2001; Ohno et al., 2004). Additionally, we previously found that
extracellular Syntenin-1 in human colostrum could preferentially
induce IgA production from cord blood naive B cells (Sira et al.,
2009).
IL-5/IL-5R signaling, one of the pathways interacting with
Syntenin-1, was  reported to maintain mouse B-1 B cells and
promote secretion of mucosal IgA (Moon et al., 2004). IL-5 also
promotes eosinophil differentiation in humans and mice (Hiroi
et al., 1999; Kopf et al., 1996; Moon et al., 2004; Yoshida et al.,
1996). Structurally, IL-5R consists of two distinct subunits, an
s article under the CC BY-NC-SA license (http://creativecommons.org/licenses/
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L-5R-speciﬁc  subunit (IL-5R)  and a common  subunit for the
M-CSF receptor family (Mita et al., 1989). Syntenin-1 was  reported
o associate with the cytoplasmic tail of IL-5R through the PDZ
PSD-95/Discs large/zO-1) domain and to interact directly with the
ranscription factor Sox4 (Beekman et al., 2009, 2012; Geijsen et al.,
001). Interestingly, Sox4 promotes B cell development, as deter-
ined by analysis of Sox4 KO mice (Schilham et al., 1996; Sun et al.,
013).
Although these various functions of Syntenin-1 in vitro have
een well reported including the relationship with IL-5R, little is
nown about the distribution and role of this protein in vivo. To
larify the physiological role(s) of Syntenin-1 in vivo, we  generated
 Syntenin-1 KO mouse strain by gene targeting in this study. We
ound that Syntenin-1 KO mice showed no obvious signs of diseases
nder speciﬁc pathogen-free conditions and the Syntenin-1 was
idely expressed, particularly in immunologically related organs
nd CNS. In addition, we focused on the relationship between
yntenin-1 and IL-5 signaling in gut-associated tissues and found
hat Syntenin-1 was not essential for the maintenance of IL-5-
esponding cells, and rather negatively regulated immunoglobulin
roduction in the intestine.
aterials and methods
eneration of Syntenin-1 KO mice
Animal care and experimental protocols were approved by the
nimal Experiment Committee of the University of Toyama (Autho-
ization No. A2012-MED-35) and were carried out in accordance
ith the Guidelines for the Care and Use of Laboratory Animal of
he University of Toyama.
A bacterial artiﬁcial chromosome (BAC) genomic clone (RP24-
01N) originating from the DNA of C57BL/6 mice and containing
yntenin-1 was obtained from BACPAC Resource Center CHORI
Oakland, CA). A counter-selection BAC modiﬁcation kit (Gene
ridges, Dresden, Germany) and a MultiSite Gateway Three-
ragment Vector Construction kit (Invitrogen, Carlsbad, CA) were
odiﬁed for the targeting vector construction. The nucleotide
equence of the mouse genome was obtained from the National
enter for Biotechnology Information (NCBI Map  Viewer, Mus
usculus Build 37.1) and the initiation site of translation in
yntenin-1 (the A of ATG) refers to position +1 and the proceed-
ng residues are indicated by negative numbers in this report.
he 5′ arm of ∼5 kbp (base pair) (Nos. −4769 to −334) and 3′
rm of ∼5 kbp (Nos. +322 to +4947) were subcloned into the
DONR P4-P1R and pDONER P2R-P3 vectors, respectively, using
he counter-selection BAC modiﬁcation kit. The 655-bp Syntenin-
 (Nos. −333 to +321) gene fragment containing exon 2, part of
ntron 1, and part of intron 2 was ampliﬁed by PCR and sub-
loned between two loxP sequences of a modiﬁed pDONR 221
ector containing a pgk-Neo cassette ﬂanked by two  FRT sites. To
onstruct the targeting vector, these three plasmids were direc-
ionally subcloned into pDEST R4-R3 containing the diphtheria
oxin gene (MC1-DTA) by MultiSite Gateway LR recombination
eaction. The targeting vector linearized with NotI was electro-
orated into the embryonic stem (ES) cell line RENKA derived
rom the C57BL/6N strain (Fukaya et al., 2006) as previously
escribed (Miya et al., 2008). After the selection with G418,
ecombinant ES clone was identiﬁed by Southern blot analy-
is using the 5′ probe (Nos. −5412 to −4923) on SpeI-digested
enomic DNA, the 3′ probe (+6740 to +7093) on ApaI-digested
enomic DNA, and the Neo probe (Miya et al., 2008) on ApaI-
igested genomic DNA. The obtained recombinant ES clone was
ransfected with the pCre-Pac plasmid (Taniguchi et al., 1998)
nd pCAGGS-FLP plasmid (Gene Bridges, Dresden, Germany)gy 220 (2015) 597–604
by electroporation to delete exon 2 and the pgk-neo cassette,
respectively. The PCR ampliﬁed fragments were veriﬁed using
the DNA sequencer ABI PRISM 3100 (Perkin-Elmer, Foster
City, CA).
The obtained clone was injected into eight-cell stage embryos
of the mouse strain ICR. The embryos were cultured to the blas-
tocyst stage and transferred to the pseudopregnant ICR mouse
uterus. The resulting male chimeric mice were crossed with
female C57BL/6 mice to establish the mutant mouse line. The
Syntenin-1 KO mice were further genotyped by PCR using the
following primers; 5′ forward, 5′-TGACCCTGGTTTAGCTGAGGA-3′;
5′ reverse, 5′-TCTGTTCCCACAGCTACCCAA-3′; and 3′ reverse, 5′-
GCTCACAACCGTCTAACTCCAAC-3′ (Fig. 1A).
Western blotting
At the age of 6 weeks, wild type (WT) and Syntenin-1 KO mice
were deeply anesthetized with pentobarbital sodium (100 mg/kg
body weight, intraperitoneal injection) and then perfused trans-
cardially with ice-cold PBS. Tissues were quickly removed and
homogenized in Mammalian Tissue Extraction Reagent (Pierce,
Rockford, IL) with Protease Inhibitor (Nacalai, Kyoto, Japan).
The homogenate was  centrifuged at 14,500 rpm for 15 min to
remove large debris. The protein concentration was determined
using a BCA Protein Assay kit (Pierce) and the protein sam-
ples were diluted at 1:1 in a sample buffer (50 mM Tris–HCl,
pH 8.2, 2% SDS, 10% glycerol, 6% 2-mercaptoethanol, and 0.01%
bromophenol blue). After denaturation by heating at 95 ◦C for
5 min, 30 g of proteins were subjected to SDS-PAGE and
transferred onto a polyvinylidene diﬂuoride membrane (Perkin-
Elmer). After blocking with 5% skim milk in Tris buffered saline
containing 0.1% Tween-20 for 1 h, the membranes were incu-
bated with rabbit polyclonal anti-Syntenin-1 antibody (1:1000,
Abcam, Cambridge, UK) or mouse monoclonal anti--actin anti-
body (1:10,000, Sigma–Aldrich, St. Louis, MO)  overnight at 4 ◦C,
then with HRP-conjugated goat anti-rabbit IgG (1:25,000, Bio-
Rad, Richmond, CA) or goat anti-mouse IgG (1:25,000, Bio-Rad)
for 1 h. Protein bands were detected using the ECL chemilu-
minescence detection system (GE Healthcare, Buckinghamshire,
UK).
Antibodies and reagents for ﬂow cytometry
Antibodies used for ﬂow cytometry were anti-mouse B220
(RA3-6B2), CD3 (145-2C11), CD5 (53–7.3), CD19 (1D3), CD23
(B3B4), and CD45 (30-F11) antibodies purchased from eBioscience
(San Jose, CA) and anti-mouse CD21/35 (7G6), surface-IgA (sIgA)
(C10-3), and Siglec-F (E50-2440) antibodies purchased from BD
Biosciences (San Diego, CA). FcRs were blocked with anti-mouse
FcR (2.4G2). Flow cytometry was performed using a FACSCanto II
(BD Biosciences). Dead cells were gated out by 7-aminoactinomycin
D staining (BD Biosciences). FlowJo (Tree Star, Ashland, OR) was
used for analysis.
Preparation of lamina propria cells
To obtain lamina propria (LP) cells, the small and large
intestines were harvested, and Peyer’s patchs (PPs) and cecal
patches were removed. The intestines were then opened lon-
gitudinally, washed twice with 40 ml  of Ca2+- and Mg2+-free
HBSS (Sigma–Aldrich) supplemented with 5% FCS, 1 mM DTT,
and 5 mM EDTA and then incubated at 37 ◦C for 40 min
with shaking at 150 rpm. Tissues were minced and incu-
bated with RPMI 1640 (Invitrogen) supplemented with 5%
FCS. To the small intestine tissues, 1 mg/ml  collagenase type I
K. Tamura et al. / Immunobiology 220 (2015) 597–604 599
Fig. 1. Generation of Syntenin-1 KO mice with C57BL/6 genetic background. (A) Schematic representations of Syntenin-1 gene, targeting vector, targeted gene, and Syntenin-1
KO  gene. The coding and noncoding regions of Syntenin-1 exons are indicated by closed and open boxes, respectively. Met  in exon 2 is the initiation site of translation in
Syntenin-1.  Inserted lox, FRT, and neomycin resistance gene (Neo) are shown. The relevant restriction enzyme sites (ApaI and SpeI), the location of probes used (5′probe, neo
probe, and 3′probe), and the PCR primers (5′forward, 5′reverse, and 3′reverse) are indicated. DTA, diphtheria toxin fragment A; BSK, pBluescript. (B) PCR analysis of genomic
DNA  from Syntenin-1+/+ (+/+), Syntenin-1+/− (+/−), and Syntenin-1−/− (−/−) mice. The 5′forward, 5′reverse, and 3′reverse primers were mixed at a molar ratio of 2:1:1. The
p in-1 p
a th ant
p
(
t
w
a
o
(
1
c
E
P
s
i
m
m
Aositions of DNA size markers are indicated on the left side. (C) Expression of synten
nd  Syntenin-1−/− (−/−) mice were separated by SDS-PAGE and immunoblotted wi
rotein  size markers are indicated on the right side.
Sigma–Aldrich) was added, and 2 mg/ml  collagenase was  added
o the large intestine tissues. The tissues were then incubated
ith 100 ng/ml DNase I (Roche Diagnostics, Indianapolis, IN)
t 37 ◦C for 40 min  with stirring. Collected cells were placed
n the boundary between 40/75% concentrations of Percoll
GE Healthcare, Piscataway, NJ) solution and centrifuged at
800 rpm at 20 ◦C for 20 min. After centrifugation, the collected
ells were washed and used as LP lymphocytes.
LISA
Freshly collected fecal samples were weighed, dissolved in
BS (0.1 g/ml), and centrifuged at 15,000 rpm for 5 min. The
upernatants were used as fecal extract. The levels of each
mmunoglobulin isotype in fecal extract and serum were deter-
ined by sandwich ELISA using antibodies speciﬁc for each
urine immunoglobulin isotype (Southern Biotech, Birmingham,
L) according to a protocol.rotein in spleen. Spleen homogenates from Syntenin-1+/+ (+/+), Syntenin-1+/− (+/−),
i-Syntenin-1 antibody (upper) and anti--actin antibody (lower). The positions of
Splenic B cell puriﬁcation and cell culture
For collection of resting B cells, single cell suspensions pre-
pared from the spleen isolated from WT  and Syntenin-1 KO mice
were puriﬁed by magnetic-activated cell sorting (MACS) nega-
tive selection using biotin-conjugated anti-mouse CD43 antibody
(S7, BD Bioscience) and streptavidin MicroBeads (Miltenyi Biotec,
Auburn, CA). The puriﬁed resting B cells were cultured at a con-
centration of 2 × 105 cells/well in RPMI 1640 with 10% FCS, 50 M
2-mercaptoethanol, 100 U/ml penicillin, and 100 g/ml strepto-
mycin. 1 g/ml LPS (Sigma–Aldrich), 1 ng/ml TGF- (R and D
Systems, Minneapolis, MN), and/or 5 ng/ml IL-5 (R and D Systems)
were added to the culture to induce IgA production. 0.1 or 1 g/ml
LPS (Sigma–Aldrich) were used to induce IgM production. 1 g/ml
anti-CD40 antibody (R and D Systems) and 50 ng/ml IL-4 (R and D
Systems) were added to induce IgG1 production. The concentration
of IgA, IgM and IgG1 in the supernatants was  measured by ELISA on
day 7, day 5 and day 5, respectively.
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NA extraction from fecal samples and real-time PCR
Fecal samples were collected for 24 h from individually housed
yntenin-1 KO and WT  littermates (6 weeks of age) and stored at
20 ◦C until analysis. DNA extraction was performed on the fecal
amples using DNA stool mini kit (Qiagen, Venlo, The Netherlands).
uantitative real-time PCR assays of 16S ribosomal RNA (rRNA)
ene were performed by Cosmobio Co. (Sapporo, Japan) using the
ethod of Matsuki et al. (2002, 2004). Three targets were analyzed:
ll bacteria, phylum Firmicutes and Bacteroidetes. The relative ratio
f each phylum to all bacteria was measured.
tatistical analysis
All values are represented as mean ± SD. The statistical sig-
iﬁcance of difference between WT  and Syntenin-1 KO mice was
etermined by two-tailed Student’s t test. Values of p < 0.05 indicate
 statistically signiﬁcant difference.
esults
eneration of Syntenin-1 KO mouse strain
To disrupt the Syntenin-1 locus in ES cells derived from the
57BL/6 mouse strain, we constructed a targeting vector to intro-
uce the loxP sequence into intron 1 and another loxP and the
eo cassette ﬂanked with FRT sequences into intron 2 (Fig. 1A).
e obtained an ES cell clone in which the expected homologous
ecombination occurred at the Syntenin-1 locus, as detected by
outhern blot analysis. The ES cells were treated with Cre and FLP
ecombinases transiently to delete exon 2 containing the initiation
ite of translation of Syntenin-1 and the Neo cassette, respectively.
himeric mice derived from this clone were mated with C57BL/6
ice to establish the mutant mouse line. The gene deletion in the
utant mice was conﬁrmed by Southern blot (data not shown) and
CR analyses (Fig. 1B). Syntenin-1 protein expression was exam-
ned using the homogenate of spleen by Western blot analysis.
he rabbit anti-Syntenin-1 antibody recognized a protein detected
s a band of 32 kDa corresponding to Syntenin-1 in the WT  mice,
hereas the band showed decreased intensity in the case of het-
rozygous mutant mice, and not detected in homozygous mutant
ice (Fig. 1C). These ﬁndings indicate that Syntenin-1 was success-
ully disrupted in the mutant mice.
Mice lacking Syntenin-1 were born at the expected Mendelian
atio (Supplementary Table 1). The Syntenin-1 KO mice thrived and
eproduced as well as their WT  littermates and showed no obvious
igns of diseases under speciﬁc-pathogen free conditions during
he ﬁrst 1 year of life.
yntenin-1 protein was widely expressed, especially in
mmunologically related organs and CNS
To evaluate the detailed expression pattern of the Syntenin-1
rotein in vivo, equal amounts of the protein from various organs of
T mice were examined by Western blotting (Fig. 2). The Syntenin-
 protein was widely expressed in mouse tissues, and relatively
igh expression levels were detected in the spleen, thymus, and
rain. The Syntenin-1 expression levels in the liver and kidney
ere lower than those in the other tissues. We  used lysates of
uman embryonic kidney (HEK) 293 cells transfected with a human
yntenin-1 expression plasmid as a positive control. The Syntenin-
 protein was not detected in any organs of Syntenin-1 KO mice
Fig. 2 and data not shown), suggesting the speciﬁcity of the primary
ntibody used against Syntenin-1.gy 220 (2015) 597–604
The number of IL-5-responding cells was not affected in
Syntenin-1-deﬁcient mice
IL-5 signaling is a key regulator for the maintenance of B-
1 B cells, IgA production, and eosinophils in mice (Hiroi et al.,
1999; Moon et al., 2004; Tominaga et al., 1991). To clarify whether
Syntenin-1 is involved in the development and maintenance of
the IL-5-responding cells, we  examined the number of lympho-
cytes and eosinophils in the peritoneal cavity (PC), mesenteric
lymph node (MLN), PP, and small and large intestinal lamina
propria (S-LP and L-LP, respectively). The proportions of B220+
sIgA−, B220+sIgA+, and B220−sIgA+ B cells in the S-LP and L-LP
and B220+sIgA− and B220+sIgA+ B cells in PP and MLN, as well
as CD3+ T cells, were normal in Syntenin-1 KO mice (Supple-
mentary Fig. 1A). Siglec-F+ eosinophils in the S-LP and L-LP of
Syntenin-1 KO mice also normally developed (Supplementary Fig.
1B). B-1a and B-1b cells (characterized as CD19+CD21−CD23−CD5+
and CD19+CD21−CD23−CD5−, respectively) and conventional B-
2 cells in PC seemed to be not affected by Syntenin-1 deﬁciency
(Supplementary Fig. 1C). The number of the analyzed immune cells
showed no signiﬁcant differences between Syntenin-1 KO and WT
mice (Table 1). These results suggest that Syntenin-1 little affected
on the development of lymphocytes and eosinophils in the steady
state.
Production of fecal immunoglobulins were increased in
Syntenin-1-deﬁcient mice
Given that IL-5 is a key cytokine for IgA production, isotype-
speciﬁc ELISA was performed to determine levels of IgA together
with those of IgG1 and IgM in the fecal extract and serum in
Syntenin-1 KO and WT  mice. Although the levels of immunoglob-
ulins in the serum did not change, IgA, IgG1 and IgM levels in
the fecal extract increased signiﬁcantly in Syntenin-1 KO mice
(Fig. 3Aand B). These results showed that Syntenin-1 negatively
regulates immunoglobulin production in the intestine.
In vitro analysis of immunoglobulins production
As intestinal immunoglobulin production was  increased in
Syntenin-1 KO mice, we next examined the ability of B cells to
secrete immunoglobulins in WT  and Syntenin-1 KO mice in vitro.
We puriﬁed splenic resting B cells by magnetic cell isolation and
cultured them in the presence of LPS, TGF-, and IL-5 to induce IgA
secretion; LPS to induce IgM secretion; IL-4 and anti-CD40 antibody
to induce IgG1 secretion. IgA production was signiﬁcantly higher
in B cells derived from Syntenin-1-deﬁcient mice than in B cells
derived from WT  mice (Fig. 4A). IgM production of Syntenin-1 KO B
cells stimulated with only LPS was  also increased (Fig. 4B). IgG1 pro-
duction had no signiﬁcant difference between these mouse strains
(Fig. 4C). These results support the idea that Syntenin-1 negatively
regulates immunoglobulin production in the intestine and suggest
that such an enhanced immunoglobulin production occurs in a B
cell-intrinsic manner.
Distribution of intestinal microbiota was inﬂuenced in
Syntenin-1-deﬁcient mice
Mucosal immunity including intestinal secretory immunoglob-
ulins is closely related to microbiota to maintain intestinal
homeostasis (Strugnell and Wijburg, 2010). The obtained results
in Syntenin-1 KO mice raise a question whether a distribution of
intestinal microbial ﬂora could be inﬂuenced. We next examined
the percentages of total 16S rRNA gene of the phylum Firmicutes
and Bacteroidetes, which consist mostly of mouse intestinal micro-
biota. The percentage of Firmicutes in the stool of Syntenin-1 KO
K. Tamura et al. / Immunobiology 220 (2015) 597–604 601
Fig. 2. Expression pattern of syntenin-1 protein. Western blot analysis of protein extracts from cerebrum, cerebellum, hippocampus, thymus, heart, lung, liver, spleen, kidney,
and  small intestine in WT mice and cerebrum in Syntenin-1 KO mice using anti-Syntenin-1 antibody (upper panels) and anti--actin antibody (lower panels). Equal amounts
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xperiments.
ice was signiﬁcantly higher than WT  mice, although the percent-
ge of Bacteroidetes and the ratio of Firmicutes to Bacteroidetes were
ot signiﬁcantly different (Fig. 5).
iscussion
We  have generated a Syntenin-1 KO mouse strain to clarify the
unction(s) of Syntenin-1 in vivo. Although Syntenin-1 was widely
xpressed in mouse organs, homozygous Syntenin-1-deﬁcient mice
howed no obvious signs of diseases. We  found that the levels of
ecal immunoglobulins in Syntenin-1 KO mice were higher than
hose in WT  mice. We  also showed that the levels of IgA and IgM
ecretion from LPS-stimulated splenic B cells were signiﬁcantly
igher in Syntenin-1 KO mice, therefore the mechanism underly-
ng enhanced fecal immunoglobulins production in Syntenin-1 KO
ice is likely B cell-intrinsic. Additionally, we indicated a possi-
ility that the intestinal microbiota was inﬂuenced in Syntenin-1
O mice. Taken together, our results imply that Syntenin-1 has a
unction to maintain the intestinal homeostasis in vivo.
Structurally, Syntenin-1 is a 32-kDa protein with two PDZ
omains (Das et al., 2012). The PDZ domains can bind to short
mino acid sequences at the C-terminal end of the transmembrane
r intracellular proteins (Chimura et al., 2011). Through the PDZ
omains, Syntenin-1 is capable to bind to various proteins, such
s syndecans, the tyrosin kinase Src, IL-5R, CD63, Delta1, and
able 1
umbers of sIgA+ cells, T cells, eosinophils, and B-1a, B-1b, and B-2 cells in gut-associated
Syntenin-1 S-LP L-LP 
B220+sIgA− 1.4 ± 0.3 3.0 ± 0
B220−sIgA+ 19.6 ± 8.2 1.1 ± 0
B220+sIgA+ 0.1 ± 0.1 0.1 ± 0
CD3+T cell 5.4 ± 3.3 1.3 ± 0
−/−  Eosinophil 2.0 ± 1.8 0.2 ± 0
B-1a 
B-1b  
B-2  
B220+sIgA− 1.7 ± 1.1 2.6 ± 1
B220−sIgA+ 19.6 ± 10.3 1.1 ± 0
B220+sIgA+ 0.1 ± 0.1 0.1 ± 0
+/+  CD3+T cell 5.2 ± 1.7 1.4 ± 0
Eosinophil 1.8 ± 1.3 0.3 ± 0
B-1a 
B-1b  
B-2  
he results indicate the mean cell numbers ± SD (×105) calculated on the basis of Supplem
yntenin-1 KO mice and WT mice. S-LP, small intestinal lamina propria; L-LP, large intesti
avity;  sIgA, surface-IgA.n embryonic kidney (HEK) 293 cells (5 g) transfected with the human Syntenin-1
re indicated on the right side. Data are representative of at least three independent
adhesion molecules, for synaptic formation in the CNS (Boukerche
et al., 2008; Estrach et al., 2007; Geijsen et al., 2001; Grootjans
et al., 1997; Hirbec et al., 2005; Jannatipour et al., 2001; Ohno et al.,
2004; Pols and Klumperman, 2009). In general, several PDZ pro-
teins are reported to act as a negative regulator of various signals
and transcription factors (Alewine et al., 2006; Gupta et al., 2012;
Stephenson et al., 2007). In fact, Chen et al. reported that Syn-
tenin speciﬁcally interacted with TNF receptor associated factor 6
(TRAF6) and played inhibitory role in TLR4-mediated NF-kB acti-
vation signaling pathway (Chen et al., 2008). Therefore, Syntenin-1
could potentially inhibit the signaling pathway of immunoglobulin
production.
Although the interacting partners of Syntenin-1 were well
reported, little has been known about the distribution of the
Syntenin-1 protein in vivo. Jeon et al. analyzed the expression
pattern of the Syntenin protein in mouse embryos by immuno-
histochemistry (Jeon et al., 2013). They reported that the Syntenin
protein was detected temporally during an early developmental
period, and that Syntenin may  play a prominent role in cell prolifer-
ation and differentiation in normal mouse development. However,
in this study we  found that the Syntenin-1 protein was widely
expressed in adult mouse organs, especially in the spleen, thymus,
and brain. Our expression data are consistent with various reports
which describe the functions of Syntenin-1 in the immune system
and CNS (Gordon-Alonso et al., 2012; Jannatipour et al., 2001; Koroll
 lymphoid tissues and peritoneal cavity.
MLN  PP PC
.9 11.1 ± 3.2 8.3 ± 2.0
.4
.1 1.0 ± 0.3 1.0 ± 0.4
.6 22.4 ± 9.5 2.3 ± 0.5
.1
2.9 ± 1.5
0.5 ± 0.2
5.8 ± 1.1
.0 11.1 ± 7.1 10.5 ± 3.3
.4
.0 1.1 ± 0.4 1.3 ± 0.5
.7 20.7 ± 13.2 2.7 ± 1.2
.2
4.7 ± 1.5
0.9 ± 0.4
6.0 ± 3.0
entary Fig. 1 (n = 5 for each group). There were not signiﬁcantly different between
nal lamina propria; MLN, mesenteric lymph node; PP, Peyer’s patch; PC, peritoneal
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Fig. 3. Immunoglobulin levels in the fecal extract and serum of Syntenin-1 KO mice.
The  concentrations of IgA, IgG1, and IgM in fecal extracts (A) and serum (B) in WT (©)
and Syntenin-1 KO () mice were determined by isotype-speciﬁc ELISA. Each spot
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Fig. 4. Increased levels of IgA and IgM secretion from B cells obtained from Syntenin-
1  KO mice in vitro. Puriﬁed splenic resting B cells from WT () and Syntenin-1 KO ()
mice  were cultured with LPS, TGF- and/or IL-5 for 7 days to induce IgA secretion
(A),  LPS for 5 days to induce IgM secretion (B), and IL-4 and anti-CD40 antibody for 5
days to induce IgG1 secretion (C). The levels of immunoglobulins in the supernatants
were measured by ELISA. Data are shown as mean ± SD and are representative ofepresents an individual mouse (6–8 weeks old). The mean levels of immunoglob-
lins are presented as bars. Asterisks indicate statistically signiﬁcant differences
*p  < 0.05), as calculated by two-tailed Student’s t test.
t al., 2001; Sala-Valdes et al., 2012) and imply that Syntenin-1 may
lay important roles in these organs.
Despite the broad expression of the Syntenin-1 protein in all
he organs analyzed, the homozygous deletion of Syntenin-1 was
ot lethal, and the Syntenin-1 KO mice showed no obvious signs
f diseases under speciﬁc pathogen-free conditions. It is possible
hat some redundant proteins may  provide compensatory signals to
aintain the homeostasis in vivo. In mice and humans, Syntenin has
wo isoforms, Syntenin-1 and Syntenin-2. Syntenin-2 shares 61%
dentity in amino acid sequence with Syntenin-1 in mice. Although
ittle is known about the functions of Syntenin-2, it is possible that
he presence of Syntenin-2 could compensate for the functions of
yntenin-1 in Syntenin-1 KO mice. Dual deletion of those Syntenin
enes might reveal their roles in immunity.
In this study, we focused on the relationship between Syntenin-
 and IL-5 signaling. IL-5 is one of the key regulators in mucosal
mmunity in mice, especially the development of B-1 B cells and
gA-producing cells and the production of intestinal IgA (Hiroi
t al., 1999; Moon et al., 2004; Tominaga et al., 1991). Because
yntenin-1 is reported to interact with IL-5R in vitro and may
ffect IL-5 signaling (Geijsen et al., 2001), we investigated the
ole(s) of Syntenin-1 in gut-associated lymphoid organs. However,
he lymphocyte populations in gut-associated lymphoid tissues
ere not signiﬁcantly different between Syntenin-1 KO mice and
T mice, and we found that the levels of immunoglobulins in fecal
xtract were higher in Syntenin-1 KO mice. These results suggest
hat Syntenin-1 plays only minor roles in the IL-5/IL-5R pathwaytwo  or three independent experiments performed in triplicate. Asterisks indicate
statistically signiﬁcant difference (*p < 0.05), as calculated by two-tailed Student’s t
test.
in the mucosal immune system and rather negatively regulates
immunoglobulin production in the intestine.We showed that the IgA and IgM production from stimulated
spleen B cells increased in Syntenin-1 KO B cells. Under physiolog-
ical conditions, intestinal B cells differentiate into plasma cells via
K. Tamura et al. / Immunobiolo
Fig. 5. Percentage of total 16S rRNA gene of phylum Firmicutes and Bacteroidetes
in stool from individually housed Syntenin-1 KO () and WT () lettermate mice
(n  = 5). Quantitative real-time PCR assays of 16S ribosomal RNA (rRNA) gene were
performed by using total bacterial primers and phylum-speciﬁc primers. The relative
ratio of each phylum to total bacteria was measured. Data are shown as mean ± SD
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Geijsen, N., Uings, I.J., Pals, C., Armstrong, J., McKinnon, M.,  Raaijmakers, J.A., Lam-nd  an asterisk indicates statistically signiﬁcant differences (*p < 0.05), as calculated
y  two-tailed Student’s t test.
 cell-dependent and T cell-independent pathways, and secreted
mmunoglobulins at LP are then transported to the lumen by
mmunoglobulin receptors (Strugnell and Wijburg, 2010; Horton
nd Vidarsson, 2013). We  showed the lymphocyte populations
ncluding intestinal B cells and B220−IgA+ cells (which represent
lasma cells) were not signiﬁcantly different and IgA secreting cells
n LP were not also different by using ELISPOT assays (data not
hown). Although the precise mechanisms were not delineated
n this study, our in vitro results indicate that such an enhanced
mmunoglobulin production in the intestine is caused by exces-
ive immunoglobulin production of individual Syntenin-1-deﬁcient
lasma cells.
Mucosal IgA plays crucial roles in host defense and mainte-
ance of normal gut microbiota (Fagarasan et al., 2002; Horton and
idarsson, 2013; Strugnell and Wijburg, 2010; Suzuki et al., 2004).
dditionally, recent studies have shown that mucosal IgM and
gG can also provide humoral protection from various pathogens
Horton and Vidarsson, 2013; Saeland et al., 2003; Stapleton et al.,
011). On the other hand, mucosal IgG or IgM production is exces-
ively increased in patients with an inﬂammatory bowel disease
uch as ulcerative colitis and Crohn’s disease (Helgeland et al., 1992;
acpherson et al., 1996; Thoree et al., 2002). In this manner, the
elationship between host immunity and intestinal microbiota is
ssential to maintain homeostatic balance in the gut. In this study,
e showed that a distribution of intestinal microbiota in Syntenin-
 KO mice could be inﬂuenced at the phylum level. Although the
etailed analysis at the genus level was not examined in this study,
t is possible that Syntenin-1 is involved in the maintenance of
ormal intestinal microbiota and mucosal immune balance by reg-
lating immunoglobulin production.
Previously, we demonstrated that Syntenin-1 exists in the
uman colostrum and could induce IgA production from naive B
ells (Sira et al., 2009). In the present study, we  found the nega-
ive regulation of Syntenin-1 in IgA production. These incompatible
unctions of Syntenin-1 may  be due to differences among species
r effector sites. As our present data might be inﬂuenced by the
unction of extracellular Syntenin-1 in milk, we  analyzed litter-
ate offspring from heterozygous breeding pairs to exclude such
ifferences in components of milk in this study. Further studies are
ecessary to clarify the role and mechanisms of actions of Syntenin-
 in the colostrum in vivo.
In summary, in this article we described the generation ofyntenin-1 KO mice and provided new evidence that Syntenin-1
egatively regulates immunoglobulin production in the intestine.
lthough Syntenin-1 has been reported to have various functionsgy 220 (2015) 597–604 603
in vitro, additional studies are needed to clarify the mechanisms in
detail, especially in vivo. Through future studies of Syntenin-1 KO
mice, it will be possible to provide novel evidence of the involve-
ment and functions of Syntenin-1 not only mucosal immunity but
also cancer metastasis, protein recycling, exosome formation, and
neural network formation.
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgments
This work was  supported by a Grant-in Aid for Scientiﬁc
Research from the Ministry of Education, Culture, Sports, Sci-
ence and Technology of Japan (Grant number 221S0003). We
thank the members of the Departments of Molecular Neuroscience,
Immunobiology and Pharmacological Genetics, and Pediatrics of
the University of Toyama for their cooperation and for their con-
structive comments on this study. We  also thank Kanako Konno for
technical assistance.
Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at http://dx.doi.org/10.1016/j.imbio.
2014.12.003.
References
Alewine, C., Olsen, O., Wade, J.B., Welling, P.A., 2006. TIP-1 has PDZ scaffold antago-
nist  activity. Mol. Biol. Cell 17, 4200–4211.
Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson,
Y.,  Depoortere, F., Coomans, C., Vermeiren, E., Zimmermann, P., David, G., 2012.
Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat. Cell Biol.
14, 677–685.
Beekman, J.M., Verhagen, L.P., Geijsen, N., Coffer, P.J., 2009. Regulation of
myelopoiesis through syntenin-mediated modulation of IL-5 receptor output.
Blood 114, 3917–3927.
Beekman, J.M., Vervoort, S.J., Dekkers, F., van Vessem, M.E., Vendelbosch, S., Brugulat-
Panes, A., van Loosdregt, J., Braat, A.K., Coffer, P.J., 2012. Syntenin-mediated
regulation of Sox4 proteasomal degradation modulates transcriptional output.
Oncogene 31, 2668–2679.
Boukerche, H., Su, Z.Z., Emdad, L., Baril, P., Balme, B., Thomas, L., Randolph, A.,
Valerie, K., Sarkar, D., Fisher, P.B., 2005. mda-9/Syntenin: a positive regulator
of  melanoma metastasis. Cancer Res. 65, 10901–10911.
Boukerche, H., Su, Z.Z., Emdad, L., Sarkar, D., Fisher, P.B., 2007. mda-9/Syntenin regu-
lates the metastatic phenotype in human melanoma cells by activating nuclear
factor-kappaB. Cancer Res. 67, 1812–1822.
Boukerche, H., Su, Z.Z., Prevot, C., Sarkar, D., Fisher, P.B., 2008. mda-9/Syntenin pro-
motes metastasis in human melanoma cells by activating c-Src. Proc. Natl. Acad.
Sci. U. S. A. 105, 15914–15919.
Chen, F., Du, Y., Zhang, Z., Chen, G., Zhang, M.,  Shu, H.B., Zhai, Z., Chen, D., 2008.
Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling. Cell. Signal
20, 666–674.
Chimura, T., Launey, T., Ito, M.,  2011. Evolutionarily conserved bias of amino-acid
usage reﬁnes the deﬁnition of PDZ-binding motif. BMC  Genomics 12, 300.
Das, S.K., Bhutia, S.K., Kegelman, T.P., Peachy, L., Oyesanya, R.A., Dasgupta, S., Sokhi,
U.K., Azab, B., Dash, R., Quinn, B.A., Kim, K., Barral, P.M., Su, Z.Z., Boukerche,
H., Sarkar, D., Fisher, P.B., 2012. MDA-9/syntenin: a positive gatekeeper of
melanoma metastasis. Front. Biosci. 17, 1–15.
Estrach, S., Legg, J., Watt, F.M., 2007. Syntenin mediates Delta1-induced cohesiveness
of  epidermal stem cells in culture. J. Cell Sci. 120, 2944–2952.
Fagarasan, S., Muramatsu, M.,  Suzuki, K., Nagaoka, H., Hiai, H., Honjo, T., 2002. Critical
roles of activation-induced cytidine deaminase in the homeostasis of gut ﬂora.
Science 298, 1424–1427.
Fukaya, M.,  Tsujita, M., Yamazaki, M., Kushiya, E., Abe, M.,  Akashi, K., Natsume, R.,
Kano, M.,  Kamiya, H., Watanabe, M.,  Sakimura, K., 2006. Abundant distribution
of TARP gamma-8 in synaptic and extrasynaptic surface of hippocampal neurons
and its major role in AMPA receptor expression on spines and dendrites. Eur. J.
Neurosci. 24, 2177–2190.mers, J.W., Koenderman, L., Coffer, P.J., 2001. Cytokine-speciﬁc transcriptional
regulation through an IL-5Ralpha interacting protein. Science 293, 1136–1138.
Gordon-Alonso, M.,  Rocha-Perugini, V., Alvarez, S., Moreno-Gonzalo, O., Ursa, A.,
Lopez-Martin, S., Izquierdo-Useros, N., Martinez-Picado, J., Munoz-Fernandez,
6 obiolo
G
G
H
H
H
H
J
J
K
K
L
M
M
M
M
M
M04 K. Tamura et al. / Immun
M.A., Yanez-Mo, M.,  Sanchez-Madrid, F., 2012. The PDZ-adaptor protein
syntenin-1 regulates HIV-1 entry. Mol. Biol. Cell 23, 2253–2263.
rootjans, J.J., Zimmermann, P., Reekmans, G., Smets, A., Degeest, G., Durr, J., David,
G.,  1997. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains.
Proc. Natl. Acad. Sci. U. S. A. 94, 13683–13688.
upta, S., Braun, A., Morowski, M.,  Premsler, T., Bender, M.,  Nagy, Z., Sickmann, A.,
Hermanns, H.M., Bosl, M.,  Nieswandt, B., 2012. CLP36 is a negative regulator of
glycoprotein VI signaling in platelets. Circ. Res. 111, 1410–1420.
elgeland, L., Tysk, C., Jarnerot, G., Kett, K., Lindberg, E., Danielsson, D., Andersen,
S.N., Brandtzaeg, P., 1992. IgG subclass distribution in serum and rectal mucosa
of  monozygotic twins with or without inﬂammatory bowel disease. Gut 33,
1358–1364.
irbec, H., Martin, S., Henley, J.M., 2005. Syntenin is involved in the developmental
regulation of neuronal membrane architecture. Mol. Cell. Neurosci. 28, 737–746.
iroi, T., Yanagita, M.,  Iijima, H., Iwatani, K., Yoshida, T., Takatsu, K., Kiyono, H., 1999.
Deﬁciency of IL-5 receptor alpha-chain selectively inﬂuences the development
of the common mucosal immune system independent IgA-producing B-1 cell in
mucosa-associated tissues. J. Immunol. 162, 821–828.
orton, R.E., Vidarsson, G., 2013. Antibodies and their receptors: different potential
roles in mucosal defense. Front. Immunol. 4, 200.
annatipour, M.,  Dion, P., Khan, S., Jindal, H., Fan, X., Laganiere, J., Chishti, A.H.,
Rouleau, G.A., 2001. Schwannomin isoform-1 interacts with syntenin via PDZ
domains. J. Biol. Chem. 276, 33093–33100.
eon, H.Y., Das, S.K., Dasgupta, S., Emdad, L., Sarkar, D., Kim, S.H., Lee, S.G., Fisher,
P.B., 2013. Expression patterns of MDA-9/syntenin during development of the
mouse embryo. J. Mol. Histol. 44, 159–166.
opf, M.,  Brombacher, F., Hodgkin, P.D., Ramsay, A.J., Milbourne, E.A., Dai, W.J., Oving-
ton, K.S., Behm, C.A., Kohler, G., Young, I.G., Matthaei, K.I., 1996. IL-5-deﬁcient
mice have a developmental defect in CD5+ B-1 cells and lack eosinophilia but
have normal antibody and cytotoxic T cell responses. Immunity 4, 15–24.
oroll, M.,  Rathjen, F.G., Volkmer, H., 2001. The neural cell recognition molecule
neurofascin interacts with syntenin-1 but not with syntenin-2, both of which
reveal self-associating activity. J. Biol. Chem. 276, 10646–10654.
in, J.J., Jiang, H., Fisher, P.B., 1998. Melanoma differentiation associated gene-9,
mda-9, is a human gamma interferon responsive gene. Gene 207, 105–110.
acpherson, A., Khoo, U.Y., Forgacs, I., Philpott-Howard, J., Bjarnason, I., 1996.
Mucosal antibodies in inﬂammatory bowel disease are directed against intesti-
nal  bacteria. Gut 38, 365–375.
atsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K., Tanaka, R.,
2004. Quantitative PCR with 16S rRNA-gene-targeted species-speciﬁc primers
for  analysis of human intestinal biﬁdobacteria. Appl. Environ. Microbiol. 70,
167–173.
atsuki, T., Watanabe, K., Fujimoto, J., Miyamoto, Y., Takada, T., Matsumoto, K.,
Oyaizu, H., Tanaka, R., 2002. Development of 16S rRNA-gene-targeted group-
speciﬁc primers for the detection and identiﬁcation of predominant bacteria in
human feces. Appl. Environ. Microbiol. 68, 5445–5451.
ita, S., Tominaga, A., Hitoshi, Y., Sakamoto, K., Honjo, T., Akagi, M.,  Kikuchi, Y.,
Yamaguchi, N., Takatsu, K., 1989. Characterization of high-afﬁnity receptors for
interleukin 5 on interleukin 5-dependent cell lines. Proc. Natl. Acad. Sci. U. S. A.
86,  2311–2315.
iya, K., Inoue, R., Takata, Y., Abe, M.,  Natsume, R., Sakimura, K., Hongou, K.,
Miyawaki, T., Mori, H., 2008. Serine racemase is predominantly localized in
neurons in mouse brain. J. Comp. Neurol. 510, 641–654.
oon, B.G., Takaki, S., Miyake, K., Takatsu, K., 2004. The role of IL-5 for mature B-1
cells  in homeostatic proliferation, cell survival, and Ig production. J. Immunol.
172, 6020–6029.gy 220 (2015) 597–604
Ohno, K., Koroll, M.,  El Far, O., Scholze, P., Gomeza, J., Betz, H., 2004. The neuronal
glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Mol.
Cell. Neurosci. 26, 518–529.
Pols, M.S., Klumperman, J., 2009. Trafﬁcking and function of the tetraspanin CD63.
Exp. Cell Res. 315, 1584–1592.
Saeland, E., Vidarsson, G., Leusen, J.H., Van Garderen, E., Nahm, M.H., Vile-Weekhout,
H.,  Walraven, V., Stemerding, A.M., Verbeek, J.S., Rijkers, G.T., Kuis, W.,  Sanders,
E.A., Van De Winkel, J.G., 2003. Central role of complement in passive protection
by  human IgG1 and IgG2 anti-pneumococcal antibodies in mice. J. Immunol.
170, 6158–6164.
Sala-Valdes, M.,  Gordon-Alonso, M.,  Tejera, E., Ibanez, A., Cabrero, J.R., Ursa, A.,
Mittelbrunn, M.,  Lozano, F., Sanchez-Madrid, F., Yanez-Mo, M.,  2012. Associa-
tion of syntenin-1 with M-RIP polarizes Rac-1 activation during chemotaxis and
immune interactions. J. Cell Sci. 125, 1235–1246.
Schilham, M.W.,  Oosterwegel, M.A., Moerer, P., Ya, J., de Boer, P.A., van de Wetering,
M., Verbeek, S., Lamers, W.H., Kruisbeek, A.M., Cumano, A., Clevers, H., 1996.
Defects in cardiac outﬂow tract formation and pro-B-lymphocyte expansion in
mice lacking Sox-4. Nature 380, 711–714.
Sira, M.M., Yoshida, T., Takeuchi, M., Kashiwayama, Y., Futatani, T., Kanegane, H.,
Sasahara, A., Ito, Y., Mizuguchi, M.,  Imanaka, T., Miyawaki, T., 2009. A novel
immunoregulatory protein in human colostrum, syntenin-1, for promoting the
development of IgA-producing cells from cord blood B cells. Int. Immunol. 21,
1013–1023.
Stapleton, N.M., Andersen, J.T., Stemerding, A.M., Bjarnarson, S.P., Verheul, R.C.,
Gerritsen, J., Zhao, Y., Kleijer, M.,  Sandlie, I., de Haas, M.,  Jonsdottir, I., van der
Schoot, C.E., Vidarsson, G., 2011. Competition for FcRn-mediated transport gives
rise to short half-life of human IgG3 and offers therapeutic potential. Nat. Com-
mun. 2, 599.
Stephenson, L.M., Sammut, B., Graham, D.B., Chan-Wang, J., Brim, K.L., Huett, A.S.,
Miletic, A.V., Kloeppel, T., Landry, A., Xavier, R., Swat, W.,  2007. DLGH1 is a
negative regulator of T-lymphocyte proliferation. Mol. Cell. Biol. 27, 7574–7581.
Strugnell, R.A., Wijburg, O.L., 2010. The role of secretory antibodies in infection
immunity. Nat. Rev. Microbiol. 8, 656–667.
Sun, B., Mallampati, S., Gong, Y., Wang, D., Lefebvre, V., Sun, X., 2013. Sox4 is required
for  the survival of pro-B cells. J. Immunol. 190, 2080–2089.
Suzuki, K., Meek, B., Doi, Y., Muramatsu, M.,  Chiba, T., Honjo, T., Fagarasan, S., 2004.
Aberrant expansion of segmented ﬁlamentous bacteria in IgA-deﬁcient gut. Proc.
Natl. Acad. Sci. U. S. A. 101, 1981–1986.
Taniguchi, M., Sanbo, M.,  Watanabe, S., Naruse, I., Mishina, M., Yagi, T., 1998. Efﬁcient
production of Cre-mediated site-directed recombinants through the utilization
of  the puromycin resistance gene, pac: a transient gene-integration marker for
ES  cells. Nucleic Acids Res. 26, 679–680.
Thoree, V.C., Golby, S.J., Boursier, L., Hackett, M.,  Dunn-Walters, D.K., Sanderson, J.D.,
Spencer, J., 2002. Related IgA1 and IgG producing cells in blood and diseased
mucosa in ulcerative colitis. Gut 51, 44–50.
Tominaga, A., Takaki, S., Koyama, N., Katoh, S., Matsumoto, R., Migita, M., Hitoshi, Y.,
Hosoya, Y., Yamauchi, S., Kanai, Y., et al., 1991. Transgenic mice expressing a B
cell growth and differentiation factor gene (interleukin 5) develop eosinophilia
and autoantibody production. J. Exp. Med. 173, 429–437.
Yoshida, T., Ikuta, K., Sugaya, H., Maki, K., Takagi, M.,  Kanazawa, H., Sunaga, S.,
Kinashi, T., Yoshimura, K., Miyazaki, J., Takaki, S., Takatsu, K., 1996. Defective B-1
cell development and impaired immunity against Angiostrongylus cantonensis in
IL-5R alpha-deﬁcient mice. Immunity 4, 483–494.
Zimmermann, P., Zhang, Z., Degeest, G., Mortier, E., Leenaerts, I., Coomans, C., Schulz,
J.,  N’Kuli, F., Courtoy, P.J., David, G., 2005. Syndecan recycling is controlled by
syntenin-PIP2 interaction and Arf6. Dev. Cell 9, 377–388.
